Valuing cure: Bridging cost-effectiveness and coverage decisions for hepatitis C therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Valuing cure: Bridging cost-effectiveness and coverage decisions for hepatitis C therapy

Published:2014-06-26 Issue:1 Volume:60 Page:12-14
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Pho Mai T.¹,Linas Benjamin P.²³

Affiliation:

1. Department of Medicine; Sections of Hospital Medicine and of Infectious Diseases and Global Health, University of Chicago; Chicago IL

2. Department of Medicine; Section of Infectious Diseases, Boston Medical Center; Boston MA

3. Department of Epidemiology; Boston University School of Public Health; Boston MA

Funder

Agency for Healthcare Research and Quality

National Institute on Drug Abuse

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.27220/fullpdf

Reference12 articles.

1. Hepatitis C virus therapy in the direct acting antiviral era;Shiffman;Curr Opin Gastroenterol,2014

2. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis;der Meer;JAMA,2012

3. Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries;Hill;Clin Infect Dis,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Was It Worth Introducing Health Economic Evaluation of Innovative Drugs in the French Regulatory Setting? The Case of New Hepatitis C Drugs;Value in Health;2019-02

2. Triplex High-Resolution Melting Assay for the Simultaneous Assessment of IFNL3 rs12979860, ABCB11 rs2287622, and RNF7 rs16851720 Genotypes in Chronic Hepatitis C Patients;The Journal of Molecular Diagnostics;2017-11

3. The Challenge of Treating Children With Hepatitis C Virus Infection;Journal of Pediatric Gastroenterology & Nutrition;2017-06

4. The Optimal Timing of Hepatitis C Therapy in Transplant Eligible Patients With Child B and C Cirrhosis;Transplantation;2017-05

5. Barriers to Treatment among New York City Residents with Chronic Hepatitis C Virus Infection, 2014;Public Health Reports;2016-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3